Semi-supervised identification of cancer subgroups using survival outcomes and overlapping grouping information

Wei Wei, Zequn Sun, Willian A da Silveira, Zhenning Yu, Andrew Lawson, Gary Hardiman, Linda E Kelemen, Dongjun Chung

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
189 Downloads (Pure)


Identification of cancer patient subgroups using high throughput genomic data is of critical importance to clinicians and scientists because it can offer opportunities for more personalized treatment and overlapping treatments of cancers. In spite of tremendous efforts, this problem still remains challenging because of low reproducibility and instability of identified cancer subgroups and molecular features. In order to address this challenge, we developed Integrative Genomics Robust iDentification of cancer subgroups (InGRiD), a statistical approach that integrates information from biological pathway databases with high-throughput genomic data to improve the robustness for identification and interpretation of molecularly-defined subgroups of cancer patients. We applied InGRiD to the gene expression data of high-grade serous ovarian cancer from The Cancer Genome Atlas and the Australian Ovarian Cancer Study. The results indicate clear benefits of the pathway-level approaches over the gene-level approaches. In addition, using the proposed InGRiD framework, we also investigate and address the issue of gene sharing among pathways, which often occurs in practice, to further facilitate biological interpretation of key molecular features associated with cancer progression. The R package "InGRiD" implementing the proposed approach is currently available in our research group GitHub webpage ( ).

Original languageEnglish
Pages (from-to)1-13
JournalStatistical Methods in Medical Research
Early online date01 Jan 2018
Publication statusPublished - 16 Jan 2018
Externally publishedYes


  • Clustering; biological pathway; cancer genomics; gene set; integrative analysis; variable selection


Dive into the research topics of 'Semi-supervised identification of cancer subgroups using survival outcomes and overlapping grouping information'. Together they form a unique fingerprint.

Cite this